KYOPRAME
Live / Registered — Registered (as of 13 May 2025)
What this means for you
Registered since 13 May 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98418327
- Registration number
- 7790486
- Mark type
- Stylized text
- Filed
- 23 Feb 2024
- Published for opposition
- 25 Mar 2025
- Registered
- 13 May 2025
- Attorney of record
- Andrew D. Price & Paula E. Hopkins
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers
Owner
- Immunocore Limited, Oxfordshire, GB
- Immunocore Limited, Oxfordshire, GB
- Immunocore Limited, Oxfordshire, GB
Prosecution history
- 13 May 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 May 2025 — REGISTERED-PRINCIPAL REGISTER
- 25 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Mar 2025 — PUBLISHED FOR OPPOSITION
- 19 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Feb 2025 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 24 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jan 2025 — ASSIGNED TO EXAMINER
- 10 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Dec 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Sept 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Sept 2024 — NON-FINAL ACTION E-MAILED
- 07 Sept 2024 — NON-FINAL ACTION WRITTEN
- 06 Sept 2024 — ASSIGNED TO EXAMINER